The funding competition of up to £15 million, which will be delivered by NHS England and NHS Improvement in partnership with SBRI Healthcare Cancer Programme will swiftly bring new and existing cancer care innovations to the NHS frontline.
The goal is to ensure practical translation of leading research and innovation, directly into cancer care, seeking to directly benefit patients by addressing the challenges of early detection and diagnosis along with the diagnostic efficiency of cancer services. Applications are welcomed for innovative, creative and future proof ideas across medical devices, digital health and equipment, behaviour intervention and new models of care.
The call is open to products at late stage of development. The aim is to accelerate these innovations into front-line clinical settings by shortening the gap between the evidence usually delivered by traditional safety/efficacy clinical trials typically required for regulatory approvals (CE marking or equivalent), and the evidence which is required by commissioners and regulators to be able to make purchasing or other recommendations/decisions. By late stage the funders mean innovations and technologies that have already proved their clinical effectiveness and are ready to be rolled out locally or nationally for real world testing.
The call is open to any innovation (e.g. medical device, in vitro diagnostic, digital health solutions, behavioural intervention, software, hardware, technology, new models of care etc.) which meets the following requirements:
The aim of the funding is to generate evidence to support rapid local/regional/national spread (not classical RCT generated evidence).
Involvement of appropriate UK clinical partners is expected and engagement with Cancer Alliances is strongly encouraged.
The NHS Long Term Plan published in January 2019 set out two bold ambitions for improving cancer outcomes:
This call is designed to support the early diagnosis ambition.
Categories of research:
The call will not support: basic research; generation of scientific and technological knowledge, or development of research ideas, hypotheses and experimental designs that have no practical commercial application, and clinical trials aimed solely at determining effectiveness of a product.
By project end the innovation should be embedded into practice in a number of NHS locations; there should be clear, high quality evaluation of the innovation against agreed criteria and a well-defined plan for further work to embed the innovation, including the possibility of follow-on funding.